Medicinal Chemistry of Diclofenac: Structure, Synthesis and SAR Medicinal Chemistry Notes • NSAIDs • Aryl/phenylacetic acid derivative ...
Medicinal Chemistry of Diclofenac: Structure, Synthesis and SAR
1. Introduction
Diclofenac is a non-steroidal anti-inflammatory drug (NSAID) belonging to the phenylacetic-acid family. Its molecule combines a phenylacetic-acid portion with a 2,6-dichlorophenyl ring through a secondary amino linkage. This apparently simple arrangement produces a highly characteristic three-dimensional shape: the two aromatic rings are forced out of the same plane, an important feature in the medicinal chemistry of diclofenac.
Diclofenac displays anti-inflammatory, analgesic and antipyretic actions. In medicinal chemistry it is particularly useful for illustrating how acidity, lipophilicity, ortho substitution and conformational twisting can work together to optimize an NSAID scaffold.
2. Chemical Identity and Structure
| Property | Details |
|---|---|
| Generic name | Diclofenac |
| Common salt | Diclofenac sodium |
| IUPAC name | 2-[2-(2,6-dichloroanilino)phenyl]acetic acid |
| Molecular formula | C14H11Cl2NO2 |
| Core medicinal-chemistry class | 2-anilinophenylacetic-acid / phenylacetic-acid NSAID |
Diclofenac (free acid)
Diclofenac sodium
3. Important Structural Features
The diclofenac molecule can be divided into four medicinally important structural regions:
- Phenylacetic-acid group: provides the acidic carboxyl group together with a one-carbon spacer from the aromatic ring.
- Second aromatic ring: contributes an additional hydrophobic/aromatic region.
- Secondary amino bridge (–NH–): joins the two aromatic systems and is part of the characteristic 2-anilinophenylacetic-acid framework.
- 2,6-Dichloro substitution: places two bulky chlorine atoms ortho to the amino linkage on the anilino ring, strongly influencing lipophilicity and the relative orientation of the two rings.
4. Synthesis of Diclofenac
Step 1 — Formation of the diphenylamine intermediate
The first key transformation constructs the aryl–nitrogen–aryl framework. 2-Chlorobenzoic acid is coupled with 2,6-dichloroaniline to produce N-(2,6-dichlorophenyl)anthranilic acid.
Step 2 — Reduction of the carboxylic acid to a benzyl alcohol
Reduction converts the aromatic carboxylic-acid substituent into a benzyl alcohol (–CH2OH). This sets up the carbon chain that will ultimately become the phenylacetic-acid side chain of diclofenac.
Step 3 — Conversion of the benzyl alcohol to benzyl chloride
The hydroxyl group is replaced by chloride, forming a benzyl chloride that is suitable for conversion into the corresponding nitrile.
Step 4 — Introduction of the nitrile carbon
Cyanide substitution gives the benzyl nitrile. This is a useful synthetic step because hydrolysis of the nitrile introduces the required carboxylic acid while retaining the –CH2– spacer.
Step 5 — Hydrolysis to diclofenac
Hydrolysis of the nitrile furnishes 2-[2-(2,6-dichloroanilino)phenyl]acetic acid, the free-acid form of diclofenac. Neutralization can subsequently furnish diclofenac sodium.
5. Structure–Activity Relationship (SAR) of Diclofenac
5.1 Two ortho substituents are strongly favored
QSAR work on close diclofenac analogues showed that the best activity was associated with halogen or alkyl substituents at both ortho positions of the anilino ring. Analogues having only one ortho substituent, no ortho substituents, or additional hydroxyl substitution were less active.
5.2 Ring twisting is a key three-dimensional requirement
The two chlorine atoms at positions 2 and 6 create steric crowding near the secondary amino linkage. This prevents the two aromatic rings from lying completely in the same plane. The resulting twisted conformation was deliberately associated with high anti-inflammatory activity during diclofenac's development and was later supported by QSAR analysis of diclofenac analogues.
5.3 Lipophilicity contributes to potency
The dichlorophenyl group increases the hydrophobic character of the molecule. Analogue studies found lipophilicity to be one of the statistically important parameters correlated with both cyclooxygenase inhibition and anti-inflammatory activity.
5.4 The acidic phenylacetic-acid portion remains central
The –CH2COOH group provides a weakly acidic center and is part of the phenylacetic-acid pharmacophore. The original design of diclofenac sought an acidity constant in the range typical of effective antirheumatic acidic NSAIDs.
| SAR feature | Medicinal-chemistry significance | Observed / expected consequence |
|---|---|---|
| Two aromatic rings | Provide hydrophobic/aromatic interaction surface | Correct relative orientation is important for activity |
| 2,6-Dichloro groups | Increase lipophilicity and create steric twisting | Double ortho substitution is associated with high activity |
| Twist angle | Defines the 3D relationship between the aromatic rings | A major QSAR parameter for diclofenac analogues |
| Secondary –NH– linker | Connects both aromatic systems in the anilino scaffold | Supports the characteristic diclofenac geometry |
| Phenylacetic acid –CH2COOH | Supplies the acidic region of the molecule | Contributes to the NSAID pharmacophore and physicochemical profile |
6. Mechanism of Action
Diclofenac exerts its anti-inflammatory and analgesic effects largely through inhibition of prostaglandin synthesis. In modern terminology this is explained primarily by inhibition of cyclooxygenase enzymes, reducing formation of prostaglandins involved in pain, inflammation and fever.
7. Key Medicinal-Chemistry Points
- Diclofenac is a phenylacetic-acid NSAID.
- Its structure contains two aromatic rings, a secondary amino bridge, two ortho chlorines and a phenylacetic-acid group.
- The 2,6-dichloro substitution is especially important because it increases lipophilicity and forces the aromatic rings to twist.
- QSAR studies identify lipophilicity and inter-ring twist angle as major determinants of activity.
- Double ortho substitution on the anilino ring is more favorable than one or no ortho substituents in close analogues.
- A classical synthesis constructs the diarylamine intermediate, converts the carboxyl group through alcohol → chloride → nitrile, and finally hydrolyzes the nitrile to the phenylacetic acid.
- Diclofenac's pharmacological effect is associated with cyclooxygenase/prostaglandin synthesis inhibition.
8. References / Source Basis
Primary textbook: Ashutosh Kar, Medicinal Chemistry, 4th revised and expanded edition, Chapter 16 (NSAIDs).
Synthesis supplement: R. S. Vardanyan and V. J. Hruby, Synthesis of Essential Drugs (diclofenac synthesis).
SAR supplement: P. Moser, A. Sallmann and I. Wiesenberg, “Synthesis and quantitative structure-activity relationships of diclofenac analogues,” Journal of Medicinal Chemistry (1990).
Design rationale: A. Sallmann, “The history of diclofenac,” The American Journal of Medicine (1986).
No comments